The Efficacy of High Flow Nasal Cannula (HFNC) in Chronic Obstructive Pulmonary Disease (COPD): a Case Report
Authors
Abstract
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms due to abnormalities of the airways and/or alveoli (that cause persistent, often progressive, airflow obstruction. The main environmental exposures leading to COPD are tobacco smoking and the inhalation of toxic particles and gases from household and outdoor air pollution. COPD could lead to worse outcomes from COVID-19. Oxygen therapy is the main treatment method for patients with COPD and hypoxemia. Compared with NIV, HFNC can significantly reduce the incidence of pressure injuries such as facial and nasal bridge rupture. And also HFNC could be a valuable and feasible treatment option for patients with COVID-19 pneumonia, with remarkable clinical advantages.
Method: This was a retrospective case report, after analysis of patient clinical data. The patient provided written informed consent to publish their case details and any accompanying images.
Results: A 63-year-old man was presented with a complaint of shortness of breath that had been felt for two days before entering the hospital. The first day of treatment, the patient complained of increasing severe shortness of breath accompanied by fever. Later on, the patient was diagnosed with an acute exacerbation of COPD accompanied by COVID-19. During 4 days of hospitalization, the patient was admitted to the ICU because of worsening breathing and was given oxygen therapy with HFNC and other drugs for 8 days. Patient showed improvement and was then discharged after seven days of hospitalization.
Conclusion: HFNC can be an alternative therapy in COPD therapy with COVID 19, because it has good tolerance and physiological effects
Similar Articles
- Annisa Astari, Imam Budi Putra, Nelva Karmila Jusuf, Relationship between Angiotensin Converting Enzyme (ACE) and Cellulite , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- Dadang Mulyawan, Osmond M. Pison, Management of Peripartum Cardiomyopathy in Severe Preeclampsia Patients in ICU , Journal of Society Medicine: Vol. 3 No. 2 (2024): February
- Dear Mohtar, Erias Erlangga, Management of Dengue Fever and Morbidly Obese in Pregnancy after C-Section , Journal of Society Medicine: Vol. 2 No. 10 (2023): October
- Widya Prawirani Siahaan, Cut Aria Arina, Kiki Mohammad Iqbal, Correlation between National Institute Health Stroke Scale and QT Dispersion In Acute Ischemic Stroke , Journal of Society Medicine: Vol. 3 No. 1 (2024): January
- Nurvira Annisa Saragih, Alfansuri Kadri, Chairil Amin Batubara, Short-Term Prognostic Model for Non-Traumatic Intracerebral Hemorrhage Patients: A Combination of Four Score, FUNC Score, and ICH Score , Journal of Society Medicine: Vol. 3 No. 1 (2024): January
- Cut Putri Hazlianda, Ika Diamanda, Current Pathogenesis and Treatment of Cutaneous Lupus Erythematosus , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
- Indah Nasution, Karina Sugih Arto, Bugis Mardina Lubis, Correlation between Glycated Hemoglobin and Calcium Levels in Pediatric with Type 1 Diabetes Mellitus , Journal of Society Medicine: Vol. 2 No. 11 (2023): November
- Akhyar Hamonangan Nasution, Aznan Lelo, Catechol-O-Methyltransferase (COMT) Enzyme Level In Preoperative Anxiety Patients , Journal of Society Medicine: Vol. 1 No. 1 (2022): October
You may also start an advanced similarity search for this article.